🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Starting the new year with a bang. Pushing the frontiers of parenchyma-sparing liver surgery. Laennec capsule tunnel approach for resection of CRLM at the hepatic cloaca straddling RHV. Mahesh Goel Shraddha Patkar GUIDO TORZILLI IHPBA A-PHPBA E-AHPBA SoMe4HPB Karolinska-HPB HPB unit Hospital del Mar

Hepatobiliarysurg_TMH Shraddha Patkar Mahesh Goel Excellent, clear dissection..

#GallBladderCancerInsights “Gall Bladder Cancer is an Indian Disease” Shraddha Patkar Part (1/5) Watch our Gall Bladder Cancer Insight Series here - bit.ly/Cancerinsights… You can view the entire Cancer Insight Series here - bit.ly/CancerInsights… Tata Memorial Hospital NationalCancerGrid

#GallbladderCancerInsights “What factors determine a patient to be fit for surgery?”Shraddha Patkar View Gallbladder Cancer Insight Series - bit.ly/Cancerinsights… Tata Memorial Hospital NationalCancerGrid

#CancerInsights #GallBladderandBileDuctCancer “What are the different treatment options available?” Dr.Shraddha Patkar Part (4/5) View Gall Bladder & Bile Duct Cancer Insights Series - bit.ly/Cancerinsights… View Cancer Insights Series here - bit.ly/CancerInsights…

Happy to share our publication in JSO in GBC...thank u sir and ma'am for all the help and guidance....thank u Kazi for the inputs

#CancerInsights #GallBladderandBileDuctCancerAwareness “Are there any minimally invasive techniques available for surgery?” Dr.Shraddha Patkar View Gall Bladder Cancer Insights Series here - bit.ly/Cancerinsights… View Cancer Insights series here - bit.ly/CancerInsights…

3 consecutive Extended Hepatectomies with Portal vein resections within a week… Pushing the boundaries… Extended resections for Hilar Cholangiocarcinomas… Mahesh Goel Shraddha Patkar Dr. Afroj Bagwan Dr T M Shah Gurudutt P. Varty Dr Niket M Shah Iswanto Sucandy MD Timothy M. Pawlik Itaru Endo

Margin negative resections for optimal oncological outcomes… often require portal vein resections!!! Karan Kale Kaival Gundavda Amir M Parray Aditya Kunte Dr. Saneya Jasmine Agarwal Swapnil Patel Amit Chopde Vikas Gupta Shravan Sharad Nadkarni Mufaddal Kazi

Key to good outcomes- Proper patient selection, preoperative optimization Meticulous preoperative planning and knowledge of anatomical variations … MDT discussions Volume augmentation Intraoperative decision making… access operability carefully; IOUS… an indispensable tool

Hepatobiliarysurg_TMH Mahesh Goel Shraddha Patkar Dr. Afroj Bagwan Dr T M Shah Dr Niket M Shah Iswanto Sucandy MD Timothy M. Pawlik Itaru Endo Three Hilars with 3 PVRs is just too good! One of the most complex of liver resections. There is no margin of error in these cases.

Publication alert 🚨 Adenosquamous GB Ca is rare, yet not so infrequently encountered in clinical practice. With the literature rather sparse regarding its management, check out our experience in managing this rare entity! Mahesh Goel Shraddha Patkar pubmed.ncbi.nlm.nih.gov/40024853/

An honour to be awarded for our research on locally advanced GBC at Korea HBP Surgery Week 2025! 🌸 Fantastic scientific program—learned a lot, made great friends 🇰🇷🇵🇭🇮🇹, and found new inspirations. Hope these connections go a long way! HBP Surgery Week 2025 Hepatobiliarysurg_TMH

After consecutive extended resections for cholangiocarcinomas... A series of Parenchyma sparing Hepatectomies (PSH) for CRLMs. Key to sucess... Appropriate use of preoperative chemo Meticulous pre-op planning Real-time intra-op navigation with IOUS & ICG Mahesh Goel Shraddha Patkar

Iswanto Sucandy MD AdventHealth NHS England Society of Robotic Surgery | SRS Intuitive Medtronic Annals of Surgical Oncology ASTS IHPBA AHPBA Jawad Ahmad Brilliant conference Humbling experience with lot to learn and look forward to in Robotic HPB. Met some old friends and made some new.

Proud to have our lead Radiation Oncologist presenting Our POLCA GB - phase III trial #ASCO 2025. The first RCT on Gallbladder Cancer from TMC, India (World)

POLCA GB#ASCO 2025 “ A GameChanger” We selected & defined patients of locally advanced Gallbladder Cancer as per predefined “TMH Criteria” and showed neoadjuvant strategies work to improve outcomes.

Hepatobiliarysurg_TMH Shraddha Patkar IHPBA IHPBA India A-PHPBA Japanese Society of HBP Surgery Gurudutt P. Varty Kaival Gundavda Proud to have our lead Radiation Oncologist presenting Our POLCA GB - phase III trial #ASCO 2025. The first RCT on Gallbladder Cancer from TMC, India (World)

POLCA GB#ASCO 2025 “ A GameChanger” We selected & defined patients of locally advanced Gallbladder Cancer as per predefined “TMH Criteria” and showed neoadjuvant strategies work to improve outcomes.

POLCA GB #ASCO2025 Preop chemoradiation (CRT) vs chemo (NACT) in LAGBC: OS benefit: mOS 21.8 vs 10.1 mo 5-yr OS 29% vs 17% CRT better downstaging → better surgery → better survival in carefully selected patients. *** A step forward for #BTC – preop CRT may be new SoC in